2015Progress in Neuro-Psychopharmacology and Biological PsychiatryOpen access

Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder

Richard De La Garza, Marcy J. Bubar, Crystal L. Carbone, F. Gerard Moeller, Thomas F. Newton, Noelle C. Anastasio, Tod A. Harper, David L. Ware, Michael Fuller, Gaylyn J. Holstein, Jason B. Jayroe, Stephen I. Bandak, Kirsten Z. Reiman, Ann Neale, Lesley B. Pickford, Kathryn A. Cunningham

Open full text 23 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 23 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Cocaine dependence, Cocaine use, Placebo, Adverse effect, Psychology, Dopamine, Medicine, Pharmacokinetics

Related papers

Back to paper searchBrowse research topicsOriginal source
Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder — Research Paper | ScholarLens